Matches in SemOpenAlex for { <https://semopenalex.org/work/W2161583721> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2161583721 endingPage "447" @default.
- W2161583721 startingPage "440" @default.
- W2161583721 abstract "In previous trials, UV therapy has been demonstrated to be effective in the treatment of localized scleroderma (LS). To date, a randomized comparison study to evaluate the efficacy and safety of different, commonly used phototherapeutic modalities in LS is still outstanding.The aim of this study was to compare the safety and efficacy of low-dose (LD) UVA1, medium-dose (MD) UVA1, and narrowband (NB) UVB phototherapy in the treatment of LS.Sixty four patients with LS were consecutively included in a prospective, open, randomized controlled 3-arm study. Severity of LS was determined by means of a clinical score, and clinical improvement was also monitored by histopathologic analysis and 20-MHz ultrasound.A total of 27 patients were treated with LD UVA1 (20 J/cm2), 18 patients received MD UVA1 (50 J/cm2), and 19 patients were treated with NB UVB dependent on their skin type. Phototherapy was performed 5 times weekly for 8 weeks. Two of the 64 patients included in this trial discontinued therapy. Skin status significantly improved in all patients who finished the treatment protocol, resulting in a reduction of the clinical score in all groups (LD UVA1, 7.6-5.0 [P < .001, 95% confidence interval 1.6-3.4]; MD UVA1, 11.1-6.6 [P < .001, 95% confidence interval 2.5-6.2]; NB UVB, 7.3-4.9 [P < .001, 95% confidence interval 1.6-3.2]). The reduction of the score was accompanied by an improvement of the visual analog scale for itching and tightness, histologic score, and 20-MHz ultrasound. MD UVA1 was significantly more effective than NB UVB (P < .05). There were no significant differences between LD UVA1 and NB UVB and the former and MD UVA1 (P > .05).We had a relatively small study sample and nonblinded assessment of primary outcome.Phototherapy, as previously reported in several noncontrolled trials, is an effective therapeutic option in LS, with a favorable risk/benefit ratio. UVA1 phototherapy should be considered among the first approaches in the management of LS." @default.
- W2161583721 created "2016-06-24" @default.
- W2161583721 creator A5006074498 @default.
- W2161583721 creator A5055279662 @default.
- W2161583721 creator A5064154139 @default.
- W2161583721 creator A5083044979 @default.
- W2161583721 creator A5086267815 @default.
- W2161583721 creator A5086486271 @default.
- W2161583721 date "2006-03-01" @default.
- W2161583721 modified "2023-10-10" @default.
- W2161583721 title "A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma" @default.
- W2161583721 cites W1481903350 @default.
- W2161583721 cites W1524382035 @default.
- W2161583721 cites W1539828188 @default.
- W2161583721 cites W1583849730 @default.
- W2161583721 cites W1968900245 @default.
- W2161583721 cites W1985958073 @default.
- W2161583721 cites W2009889077 @default.
- W2161583721 cites W2013202993 @default.
- W2161583721 cites W2017124417 @default.
- W2161583721 cites W2036737310 @default.
- W2161583721 cites W2047984438 @default.
- W2161583721 cites W2048604325 @default.
- W2161583721 cites W2048674643 @default.
- W2161583721 cites W2060900307 @default.
- W2161583721 cites W2069782911 @default.
- W2161583721 cites W2071548251 @default.
- W2161583721 cites W2073088332 @default.
- W2161583721 cites W2078757951 @default.
- W2161583721 cites W2103293527 @default.
- W2161583721 cites W2118770681 @default.
- W2161583721 cites W2121698961 @default.
- W2161583721 cites W2122058541 @default.
- W2161583721 cites W2128541752 @default.
- W2161583721 cites W4317639809 @default.
- W2161583721 doi "https://doi.org/10.1016/j.jaad.2005.11.1063" @default.
- W2161583721 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16488295" @default.
- W2161583721 hasPublicationYear "2006" @default.
- W2161583721 type Work @default.
- W2161583721 sameAs 2161583721 @default.
- W2161583721 citedByCount "210" @default.
- W2161583721 countsByYear W21615837212012 @default.
- W2161583721 countsByYear W21615837212013 @default.
- W2161583721 countsByYear W21615837212014 @default.
- W2161583721 countsByYear W21615837212015 @default.
- W2161583721 countsByYear W21615837212016 @default.
- W2161583721 countsByYear W21615837212017 @default.
- W2161583721 countsByYear W21615837212018 @default.
- W2161583721 countsByYear W21615837212019 @default.
- W2161583721 countsByYear W21615837212020 @default.
- W2161583721 countsByYear W21615837212021 @default.
- W2161583721 countsByYear W21615837212022 @default.
- W2161583721 countsByYear W21615837212023 @default.
- W2161583721 crossrefType "journal-article" @default.
- W2161583721 hasAuthorship W2161583721A5006074498 @default.
- W2161583721 hasAuthorship W2161583721A5055279662 @default.
- W2161583721 hasAuthorship W2161583721A5064154139 @default.
- W2161583721 hasAuthorship W2161583721A5083044979 @default.
- W2161583721 hasAuthorship W2161583721A5086267815 @default.
- W2161583721 hasAuthorship W2161583721A5086486271 @default.
- W2161583721 hasConcept C126322002 @default.
- W2161583721 hasConcept C141071460 @default.
- W2161583721 hasConcept C168563851 @default.
- W2161583721 hasConcept C188816634 @default.
- W2161583721 hasConcept C197934379 @default.
- W2161583721 hasConcept C2779923671 @default.
- W2161583721 hasConcept C44249647 @default.
- W2161583721 hasConcept C535046627 @default.
- W2161583721 hasConcept C71924100 @default.
- W2161583721 hasConceptScore W2161583721C126322002 @default.
- W2161583721 hasConceptScore W2161583721C141071460 @default.
- W2161583721 hasConceptScore W2161583721C168563851 @default.
- W2161583721 hasConceptScore W2161583721C188816634 @default.
- W2161583721 hasConceptScore W2161583721C197934379 @default.
- W2161583721 hasConceptScore W2161583721C2779923671 @default.
- W2161583721 hasConceptScore W2161583721C44249647 @default.
- W2161583721 hasConceptScore W2161583721C535046627 @default.
- W2161583721 hasConceptScore W2161583721C71924100 @default.
- W2161583721 hasIssue "3" @default.
- W2161583721 hasLocation W21615837211 @default.
- W2161583721 hasLocation W21615837212 @default.
- W2161583721 hasOpenAccess W2161583721 @default.
- W2161583721 hasPrimaryLocation W21615837211 @default.
- W2161583721 hasRelatedWork W1586374228 @default.
- W2161583721 hasRelatedWork W2003938723 @default.
- W2161583721 hasRelatedWork W2047967234 @default.
- W2161583721 hasRelatedWork W2089201504 @default.
- W2161583721 hasRelatedWork W2118496982 @default.
- W2161583721 hasRelatedWork W2364998975 @default.
- W2161583721 hasRelatedWork W2369162477 @default.
- W2161583721 hasRelatedWork W2439875401 @default.
- W2161583721 hasRelatedWork W4238867864 @default.
- W2161583721 hasRelatedWork W2525756941 @default.
- W2161583721 hasVolume "54" @default.
- W2161583721 isParatext "false" @default.
- W2161583721 isRetracted "false" @default.
- W2161583721 magId "2161583721" @default.
- W2161583721 workType "article" @default.